Currently out of the existing stock ratings of Mike Matson, 547 are a BUY (94.31%), 29 are a HOLD (5%), 4 are a SELL (0.69%).

Mike Matson

Work Performance Price Targets & Ratings Chart

Analyst Mike Matson works at NEEDHAM with a stock forecast success ratio of 55.14% fulfilled within 251.7 days on average.

Mike Matson’s has documented 1,026 price targets and ratings displayed on 40 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on AORT, Artivion at 08-Apr-2024.

Wall Street Analyst Mike Matson

Analyst best performing recommendations are on OCX (ONCOCYTE CORP).
The best stock recommendation documented was for OCX (ONCOCYTE CORP) at 11/9/2023. The price target of $3.6 was fulfilled within 6 days with a profit of $0.9 (33.33%) receiving and performance score of 55.56.

Average potential price target upside

ATRC AtriCure AXNX Axonics Modulation Technologies CNMD CONMED FNA Paragon 28 GMED Globus Medical HAE Haemonetics HRC Hill-Rom Holdings INMD InMode Ltd KIDS Orthopediatrics Corp LIVN LivaNova PLC LUCD Lucid Diagnostics MDT Medtronic PLC MMSI Merit Medical Systems NUVA NuVasive RMD ResMed SRDX SurModics SYK Stryker TFX Teleflex orporated VCYT Veracyte ZBH Zimmer Biomet Holdings BSX Boston Scientific Corp CSII Cardiovascular Systems GNMK GenMark Diagnostics HOLX Hologic INGN Inogen MDXG MiMedx Group NEO NeoGenomics OCX OncoCyte Corp CRY CryoLife STE STERIS plc WMGI Wright Medical Group N.V AORT Artivion PSNL Personalis PEN Penumbra MASI Masimo CMD Cantel Medical Corp IVC Invacare SWAV Shockwave Medical ENOV Enovis Corp NARI Inari Medical 

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

46

$19.46 (73.32%)

44

2 months 5 days ago

8/22 (36.36%)

$13.28 (40.59%)

218

Buy

42

$15.46 (58.25%)

50

2 months 5 days ago

7/9 (77.78%)

$9.28 (28.36%)

71

Buy

58

$31.46 (118.54%)

57

2 months 5 days ago

3/10 (30%)

$25.28 (77.26%)

432

Buy

52

$25.46 (95.93%)

50

2 months 30 days ago

2/11 (18.18%)

$17.72 (51.69%)

36

Buy

50

$23.46 (88.39%)

60

5 months 19 days ago

3/7 (42.86%)

$13.42 (36.69%)

123

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Mike Matson is most bullish on?

Potential upside of $50.55 has been obtained for CNMD (CONMED)

Which stock is Mike Matson is most reserved on?

Potential downside of -$32.13 has been obtained for MASI (MASIMO)

What Year was the first public recommendation made by Mike Matson?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?